TOCILIZUMAB IN FIBROUS DYSPLASIA OF BONE

PHASE2CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

May 5, 2013

Primary Completion Date

May 31, 2015

Study Completion Date

June 19, 2018

Conditions
Fibrous Dysplasia of Bone
Interventions
DRUG

Tocilizumab

8 mg/kg/month

DRUG

Placebo

Trial Locations (3)

69003

Service de rhumatologie, Hopital Edouard Herriot, HCL, Lyon

75010

Service de rhumatologie, Hôpital Lariboisière, Paris

Unknown

Service de Rhumatologie, Groupe Hospitalier Pellegrin, Bordeaux

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT01791842 - TOCILIZUMAB IN FIBROUS DYSPLASIA OF BONE | Biotech Hunter | Biotech Hunter